查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301048

宏基因组学市场规模、份额和趋势分析报告：按技术（鸟枪测序、16S 测序、全基因组测序）、按产品、按工作流程、按应用、按地区和细分市场趋势：2023-2030 年

Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

宏基因组学市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球宏基因组学市场预计将达到 40.2 亿美元。

从 2023 年到 2030 年，市场预计将以 14.8% 的复合年增长率扩张。 基因组学和蛋白□□质组学研究的兴起、个性化药物的日益采用以及对生物製剂的需求不断增长正在推动对测序仪的需求，从而促进该行业的增长。 例如，2022 年 8 月，Illumina, Inc. 宣布计划通过开发解决方案中心来扩大其在巴西的基因组学业务。 新设施是临床基因组学需求不断增长并加速公司在拉丁美洲的足蹟的结果。

公司增加研发投资预计将对宏基因组学在许多应用中的使用产生重大影响。 例如，2021年4月，安捷伦科技公司收购了Resolution Bioscience, Inc.，一家基于NGS的精准肿瘤学解决方案开发商。 Resolution Bioscience 的非侵入性液体活检平台与安捷伦基于组织的伴随诊断技术的结合预计将扩大安捷伦在精准肿瘤学 NGS 技术领域的市场地位。

广泛采用宏基因组学进行环境应用的另一个因素是微生物直接参与生物地球化学循环。 微生物对石油碳氢化合物等碳源的降解促使研究人员研究生物燃料生产的宏基因组学过程。 此外，未培养的微生物中存在许多未被发现的生物分子，加速了宏基因组学在农业、食品安全、化学、工业和其他相关应用中的采用。

自 COVID-19 爆发以来，生命科学和生物技术行业的主要利益相关者正在寻求跟踪、检测和治疗 COVID-19 的解决方案。 宏基因组分析在病毒检测和追踪中发挥着重要作用。 已经部署了各种序列监测平台和解决方案来有效诊断感染。 例如，2021年5月，牛津大学和甲骨文宣布建立战略合作伙伴关係，开发强大的基于云的基因组测序和分析平台，以降低冠状病毒感染的风险。

此外，政府为促进学术机构使用 NGS 平台进行研究而提供的资金将进一步增加宏基因组学工具的使用。 例如，2021 年 2 月，加拿大政府投资 5300 万美元实施多层方法诊断 COVID-19。 加拿大政府计划利用基因组测序和分析技术来实现预期结果。

宏基因组学生成的数据质量也是增加分析成本的因素之一。 数据质量很大程度上取决于测序过程中的平均运行次数。 高质量的分析是有代价的。 然而，由于 RNA-Seq 等新技术的准确性、快速结果和价格下降，其采用正在迅速增加。 据观察，测序成本每年增加5-10倍，计算能力每两年增加一倍。

宏基因组市场报告亮点

  • 按产品划分，试剂盒和试剂细分市场占有最大的市场份额。 对这些产品的批量需求很高。 试剂盒和试剂的高市场渗透率进一步推动了高收入份额。
  • 从技术角度来看，鸟枪测序领域预计将在预测期内占据最大份额，且复合年增长率最快。 读取样本中所有基因组 DNA 的能力等优势赋予了该技术竞争优势，导致研究人员越来越多地采用鸟枪法测序。
  • 从应用来看，临床诊断领域预计将在整个预测期内实现最快的复合年增长率。 旨在利用测序技术开发个性化疗法的研究举措预计将影响和推动临床研究领域的增长。
  • 按工作流程划分，2022 年测序细分市场所占份额最大。 除了采用简单的工作流程模型、对快速结果的需求以及与推动测序和数据分析服务需求的系统价格相比，每个样本的分析成本较低之外。
  • 由于专注于基因组研究的大公司和大型研究和学术机构已建立营销和分销网络，北美在 2022 年将主导全球宏基因组学行业。
  • 主要公司包括 Illumina.Inc.、Thermo Fisher Scientific, Inc.、QIAGEN 和 Promega Corporation。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
    • 信息分析
    • 市场形成和数据可视化
    • 验证和发布数据
  • 调查假设
  • 信息获取
    • 初步调查
  • 信息或数据分析
  • 市场形成和验证
  • 市场模式
  • 全球市场：计算复合年增长率
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第三章市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场趋势和展望
  • 市场动态
    • 降低测序成本
    • 生物技术和生物信息技术的发展
    • 人们对各种研究的微生物筛查越来越感兴趣
    • 基因组学新领域的出现补充了宏基因组学
  • 市场製约因素分析
    • 对计算和各种分析工具的访问有限
    • 宏基因组学的总成本很高
  • 商业环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
  • 新型冠状病毒病 (COVID-19) 的影响分析

第 4 章技术业务分析

  • 宏基因组市场：技术波动分析
  • 霰弹枪序列
    • 鸟枪法测序市场，2018-2030 年（百万美元）
  • 16S序列
    • 2018-2030 年 16S 测序市场（百万美元）
  • 全基因组测序
    • 2018-2030 年全基因组测序市场（百万美元）
  • 其他
    • 其他市场，2018-2030 年（百万美元）

第五章产品业务分析

  • 宏基因组学市场：产品变异分析
  • 试剂盒和试剂
    • 试剂盒和试剂市场，2018-2030 年（百万美元）
  • 测序和数据分析服务
    • 2018-2030 年测序和数据分析服务市场（百万美元）
  • 软件
    • 2018-2030 年软件市场（百万美元）

第 6 章：应用程序业务分析

  • 宏基因组市场：应用的变异分析
  • 环境应用
    • 2018-2030 年环境应用市场（百万美元）
  • 临床诊断应用
    • 2018-2030 年临床诊断应用市场（百万美元）
  • 药物发现应用
    • 2018-2030 年药物发现应用市场（百万美元）
  • 生物技术的应用
    • 2018-2030 年生物技术应用市场（百万美元）
  • 食品和营养应用
    • 2018-2030 年食品和营养应用市场（百万美元）
  • 其他
    • 其他市场，2018-2030 年（百万美元）

第七章工作流程业务分析

  • 宏基因组学市场：工作流程变异分析
  • 前序
    • 2018-2030 年预测序市场（百万美元）
  • 序列
    • 测序市场，2018-2030 年（百万美元）
  • 数据分析
    • 2018-2030 年数据分析市场（百万美元）

第 8 章区域业务分析

  • 2022 年和 2030 年按地区划分的宏基因组市场份额
  • 北美
    • SWOT分析
    • 北美宏基因组学市场，2018-2030 年（百万美元）
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 2018-2030 年欧洲宏基因组市场（百万美元）
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 2018-2030 年亚太宏基因组市场（百万美元）
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲宏基因组市场，2018-2030 年（百万美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 宏基因组学市场，2018-2030 年（百万美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 9 章竞争格局

  • 公司分类
  • 战略规划
  • 公司简介/列表
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc..
    • PerkinElmer, Inc.
    • Promega Corporation
    • Oxford Nanopore Technologies
    • Qiagen
    • Takara Bio, Inc.
    • Novogene Co., Ltd.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-2-68038-452-9

Metagenomics Market Growth & Trends

The global metagenomics market size is expected to reach USD 4.02 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.8% from 2023 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Metagenomics Market Report Highlights

  • By product, the kits & reagents segment accounts for the largest market share. The demand in terms of volumes is high for these products. High market penetration of kits and reagents further contributes toward their highest revenue share
  • By technology, the shotgun sequencing segment is estimated to have the largest share with the fastest CAGR over the forecast period. The advantages such as the ability to read all genomic DNA in a sample give a competitive edge to the technology resulting in the growing adoption of shotgun sequencing among researchers
  • By application, the clinical diagnostics segment is anticipated to have the fastest CAGR throughout the forecast period. Owing to the research initiatives for the development of personalized therapies using sequencing technology are expected to impact growth in the area of clinical research, hence, propelling the growth
  • By workflow, the sequencing segment held the largest share in 2022, owing to the adoption of easy workflow models, demand for rapid results, and lower cost of per sample analysis compared to the price of systems driving the demand for sequencing & data analytics services
  • North America dominated the global metagenomics industry in 2022 owing to the presence of well-established marketing and distribution network of major companies and large-sized research & academic institutes, which focus on genomic studies
  • A few of the key players include Illumina. Inc.; Thermo Fisher Scientific, Inc.; QIAGEN; and Promega Corporation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Declining expenses of sequencing
    • 3.3.2. Developments in biotechnology & bioinformatics techniques
    • 3.3.3. Rising interest in microbial screening for different investigations
    • 3.3.4. Emergence of new fields in genomics that complement metagenomics
  • 3.4. Market Restraint Analysis
    • 3.4.1. Limited accessibility to computation and different analytic tools
    • 3.4.2. High overall cost of metagenomics
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. COVID - 19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Metagenomics market: Technology Movement Analysis
  • 4.2. Shotgun Sequencing
    • 4.2.1. Shotgun Sequencing Market, 2018 - 2030 (USD Million)
  • 4.3. 16S Sequencing
    • 4.3.1. 16S Sequencing Market, 2018 - 2030 (USD Million)
  • 4.4. Whole Genome Sequencing
    • 4.4.1. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Metagenomics market: Product Movement Analysis
  • 5.2. Kits and Reagents
    • 5.2.1. Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 5.3. Sequencing & Data Analytics Services
    • 5.3.1. Sequencing & Data Analytics Services Market, 2018 - 2030 (USD Million)
  • 5.4. Software
    • 5.4.1. Software Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Metagenomics market: Application Movement Analysis
  • 6.2. Environmental Application
    • 6.2.1. Environmental Application Market, 2018 - 2030 (USD Million)
  • 6.3. Clinical Diagnostics Applications
    • 6.3.1. Clinical Diagnostics Applications Market, 2018 - 2030 (USD Million)
  • 6.4. Drug Discovery Applications
    • 6.4.1. Drug Discovery Applications Market, 2018 - 2030 (USD Million)
  • 6.5. Biotechnology Applications
    • 6.5.1. Biotechnology Applications Market, 2018 - 2030 (USD Million)
  • 6.6. Food & Nutrition Applications
    • 6.6.1. Food & Nutrition Applications Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Workflow Business Analysis

  • 7.1. Metagenomics market: Workflow Movement Analysis
  • 7.2. Pre - sequencing
    • 7.2.1. Pre - sequencing Market, 2018 - 2030 (USD Million)
  • 7.3. Sequencing
    • 7.3.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 7.4. Data Analysis
    • 7.4.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Metagenomics market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Metagenomics market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. U.S. Metagenomics market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Target Disease Prevalence
      • 8.2.4.5. Canada Metagenomics market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. Germany Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. UK Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. France Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. Italy Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Spain Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Target Disease Prevalence
      • 8.3.8.5. Denmark Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Target Disease Prevalence
      • 8.3.9.5. Sweden Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Competitive Scenario
      • 8.3.10.3. Regulatory Framework
      • 8.3.10.4. Target Disease Prevalence
      • 8.3.10.5. Norway Metagenomics market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Japan Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. China Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Target Disease Prevalence
      • 8.4.5.5. India Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Target Disease Prevalence
      • 8.4.6.5. South Korea Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Target Disease Prevalence
      • 8.4.7.5. Australia Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Target Disease Prevalence
      • 8.4.8.5. Thailand Metagenomics market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Metagenomics market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Brazil Metagenomics market, 2018 - 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Mexico Metagenomics market, 2018 - 2030 (USD Million)
    • 8.5.5. Argentina
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. Argentina Metagenomics market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. South Africa Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. Saudi Arabia Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. UAE Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Target Disease Prevalence
      • 8.6.6.5. Kuwait Metagenomics market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Profiles/Listing
    • 9.3.1. Illumina, Inc.
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Thermo Fisher Scientific, Inc.
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Bio - Rad Laboratories, Inc..
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. PerkinElmer, Inc.
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Promega Corporation
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Oxford Nanopore Technologies
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Qiagen
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Takara Bio, Inc.
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Novogene Co., Ltd.
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. F. Hoffmann - La Roche Ltd.
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 7 Global Metagenomics Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 North America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 13 U.S. Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 17 Canada Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Canada Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 21 Europe Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Europe Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Europe Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 Europe Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 26 Germany Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27 Germany Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Germany Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 30 UK Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 UK Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 UK Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 UK Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 34 France Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 France Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 France Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 France Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 38 Italy Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 39 Italy Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Italy Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Italy Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 42 Spain Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Spain Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Spain Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Spain Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 46 Denmark Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Denmark Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Denmark Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 50 Norway Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Norway Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Norway Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Norway Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 54 Sweden Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 63 China Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64 China Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 China Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 China Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 67 Japan Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 68 Japan Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Japan Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Japan Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 71 India Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 India Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 India Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 India Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 75 South Korea Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 South Korea Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 South Korea Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 South Korea Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 79 Australia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 80 Australia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 Australia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 82 Australia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 83 Latin America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 84 Thailand Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 Thailand Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Thailand Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 88 Latin America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Latin America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 Latin America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 Latin America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 92 Brazil Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 93 Brazil Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 Brazil Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Brazil Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 96 Mexico Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 97 Mexico Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Mexico Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 99 Mexico Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 100 Argentina Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 109 South Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 117 UAE Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 118 UAE Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 120 UAE Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Metagenomics Market, Workflow, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain - Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Metagenomics, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global Metagenomics Market: Technology Movement Analysis
  • Fig. 17 Global Metagenomics Market, for Shotgun Sequencing, 2018 - 2030 (USD Million)
  • Fig. 18 Global Metagenomics Market, for 16S Sequencing, 2018 - 2030 (USD Million)
  • Fig. 19 Global Metagenomics Market, for Whole Genome Sequencing, 2018 - 2030 (USD Million)
  • Fig. 20 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Metagenomics Market: Product Movement Analysis
  • Fig. 22 Global Metagenomics Market, for Kits & Reagents, 2018 - 2030 (USD Million)
  • Fig. 23 Global Metagenomics Market, for Sequencing & Data Analytics Services, 2018 - 2030 (USD Million)
  • Fig. 24 Global Metagenomics Market, for Software, 2018 - 2030 (USD Million)
  • Fig. 25 Global Metagenomics Market: Application Movement Analysis
  • Fig. 26 Global Metagenomics Market, for Environmental, 2018 - 2030 (USD Million)
  • Fig. 27 Global Metagenomics Market, for Clinical Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 28 Global Metagenomics Market, for Drug Discovery, 2018 - 2030 (USD Million)
  • Fig. 29 Global Metagenomics Market, for Biotechnology, 2018 - 2030 (USD Million)
  • Fig. 30 Global Metagenomics Market, for Food & Nutrition, 2018 - 2030 (USD Million)
  • Fig. 31 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 32 Global Metagenomics Market: Workflow Movement Analysis
  • Fig. 33 Global Metagenomics Market, for Pre - sequencing, 2018 - 2030 (USD Million)
  • Fig. 34 Global Metagenomics Market, for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 35 Global Metagenomics Market, for Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Outlook, 2021 & 2030
  • Fig. 38 Global Metagenomics Market: Region Movement Analysis
  • Fig. 39 North America Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 44 UK Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 45 France Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 53 China Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 54 India Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Metagenomics Market, 2018 - 2030 (USD Million)